Terms: = Lymphoma AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Treatment
60 results:
1. Identification of crucial genes involved in thyroid cancer development.
Kalarani IB; Sivamani G; Veerabathiran R
J Egypt Natl Canc Inst; 2023 May; 35(1):15. PubMed ID: 37211566
[TBL] [Abstract] [Full Text] [Related]
2. A Drosophila chemical screen reveals synergistic effect of MEK and DGKα inhibition in Ras-driven cancer.
La Marca JE; Ely RW; Diepstraten ST; Burke P; Kelly GL; Humbert PO; Richardson HE
Dis Model Mech; 2023 Mar; 16(3):. PubMed ID: 36861754
[TBL] [Abstract] [Full Text] [Related]
3. Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial.
Eckstein OS; Allen CE; Williams PM; Roy-Chowdhuri S; Patton DR; Coffey B; Reid JM; Piao J; Saguilig L; Alonzo TA; Berg SL; Ramirez NC; Jaju A; Mhlanga J; Fox E; Hawkins DS; Mooney MM; Takebe N; Tricoli JV; Janeway KA; Seibel NL; Parsons DW
J Clin Oncol; 2022 Jul; 40(20):2235-2245. PubMed ID: 35363510
[TBL] [Abstract] [Full Text] [Related]
4. ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data.
Moskovitz M; Dudnik E; Shamai S; Rotenberg Y; Popovich-Hadari N; Wollner M; Zer A; Gottfried M; Mishaeli M; Rosenberg SK; Onn A; Merimsky O; Urban D; Peled N; Maimon N; Bar J
Oncologist; 2022 Feb; 27(1):e76-e84. PubMed ID: 35305096
[TBL] [Abstract] [Full Text] [Related]
5. Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia.
Peng LJ; Wang SS; Guo SS; Zhang JJ; Liu YF; Rousseaux S; Khochbin S; Chen B; Wang J; Mi JQ
Immunobiology; 2022 May; 227(3):152205. PubMed ID: 35279479
[TBL] [Abstract] [Full Text] [Related]
6. Expression of miR-34a and miR-15b during the progression of cervical cancer in a murine model expressing the HPV16 E7 oncoprotein.
Ocadiz-Delgado R; Cruz-Colin JL; Alvarez-Rios E; Torres-Carrillo A; Hernandez-Mendoza K; Conde-Pérezprina JC; Dominguez-Gomez GI; Garcia-Villa E; Lambert PF; Gariglio P
J Physiol Biochem; 2021 Nov; 77(4):547-555. PubMed ID: 33937961
[TBL] [Abstract] [Full Text] [Related]
7. Design, synthesis, and antiproliferative effect of 2,9-bis[4-(pyridinylalkylaminomethyl)phenyl]-1,10-phenanthroline derivatives on human leukemic cells by targeting G-quadruplex.
Guillon J; Denevault-Sabourin C; Chevret E; Brachet-Botineau M; Milano V; Guédin-Beaurepaire A; Moreau S; Ronga L; Savrimoutou S; Rubio S; Ferrer J; Lamarche J; Mergny JL; Viaud-Massuard MC; Ranz M; Largy E; Gabelica V; Rosu F; Gouilleux F; Desplat V
Arch Pharm (Weinheim); 2021 Aug; 354(8):e2000450. PubMed ID: 33852185
[TBL] [Abstract] [Full Text] [Related]
8. Tipifarnib in Head and Neck Squamous Cell Carcinoma With
Ho AL; Brana I; Haddad R; Bauman J; Bible K; Oosting S; Wong DJ; Ahn MJ; Boni V; Even C; Fayette J; Flor MJ; Harrington K; Kim SB; Licitra L; Nixon I; Saba NF; Hackenberg S; Specenier P; Worden F; Balsara B; Leoni M; Martell B; Scholz C; Gualberto A
J Clin Oncol; 2021 Jun; 39(17):1856-1864. PubMed ID: 33750196
[TBL] [Abstract] [Full Text] [Related]
9. Inhibiting the "Undruggable" RAS/Farnesyltransferase (FTase) Cancer Target by Manumycin-related Natural Products.
Silva LR; da Silva-Júnior EF
Curr Med Chem; 2022; 29(2):189-211. PubMed ID: 33719954
[TBL] [Abstract] [Full Text] [Related]
10. Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma.
Chan JY; Lim JQ; Yeong J; Ravi V; Guan P; Boot A; Tay TKY; Selvarajan S; Md Nasir ND; Loh JH; Ong CK; Huang D; Tan J; Li Z; Ng CC; Tan TT; Masuzawa M; Sung KW; Farid M; Quek RHH; Tan NC; Teo MCC; Rozen SG; Tan P; Futreal A; Teh BT; Soo KC
J Clin Invest; 2020 Nov; 130(11):5833-5846. PubMed ID: 33016928
[TBL] [Abstract] [Full Text] [Related]
11. Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03).
Athauda A; Nankivell M; Langley RE; Alderson D; Allum W; Grabsch HI; Starling N; Chau I; Cunningham D
Eur J Cancer; 2020 Sep; 137():45-56. PubMed ID: 32745964
[TBL] [Abstract] [Full Text] [Related]
12. Anti-tumor Properties of
Xie DP; Gong YX; Jin YH; Ren CX; Liu Y; Han YH; Jin MH; Zhu D; Pan QZ; Yu LY; Lee DS; Lee J; Kim J; Park YH; Hyun JW; Kwon T; Cui YD; Sun HN
Anticancer Res; 2020 Jul; 40(7):3819-3830. PubMed ID: 32620621
[TBL] [Abstract] [Full Text] [Related]
13. The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study.
Ronsley R; Kariminia A; Ng B; Mostafavi S; Reid G; Subrt P; Hijiya N; Schultz KR
Pediatr Hematol Oncol; 2019 Nov; 36(8):468-481. PubMed ID: 31530240
[No Abstract] [Full Text] [Related]
14. Identification of microRNAs modulated by DNA hypomethylating drugs in extranodal NK/T-cell lymphoma.
Go H; Jang JY; Kim CW; Huh J; Kim PJ; Jeon YK
Leuk Lymphoma; 2020 Jan; 61(1):66-74. PubMed ID: 31441360
[TBL] [Abstract] [Full Text] [Related]
15. The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement.
Dogan S; Ng CKY; Xu B; Kumar R; Wang L; Edelweiss M; Scott SN; Zehir A; Drilon A; Morris LGT; Lee NY; Antonescu CR; Ho AL; Katabi N; Berger MF; Reis-Filho JS
Hum Pathol; 2019 Jun; 88():66-77. PubMed ID: 30946933
[TBL] [Abstract] [Full Text] [Related]
16. Anti-tumor effects of phenolic alkaloids of menispermum dauricum on gastric cancer
Wu D; Du J; Zhang Y; Su Y; Zhang H
J Cancer Res Ther; 2018 Jun; 14(Supplement):S505-S511. PubMed ID: 29970715
[TBL] [Abstract] [Full Text] [Related]
17. Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.
Rank CU; Toft N; Tuckuviene R; Grell K; Nielsen OJ; Frandsen TL; Marquart HVH; Albertsen BK; Tedgård U; Hallböök H; Ruud E; Jarvis KB; Quist-Paulsen P; Huttunen P; Wartiovaara-Kautto U; Jónsson ÓG; Trakymiene SS; Griškevičius L; Saks K; Punab M; Schmiegelow K
Blood; 2018 May; 131(22):2475-2484. PubMed ID: 29661787
[TBL] [Abstract] [Full Text] [Related]
18. [Primary testicular NK/T cell lymphoma: a clinicopathologic analysis of six cases].
Shi XL; Xie JL; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):168-171. PubMed ID: 29534354
[No Abstract] [Full Text] [Related]
19. Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer.
Latteyer S; Tiedje V; König K; Ting S; Heukamp LC; Meder L; Schmid KW; Führer D; Moeller LC
Endocrine; 2016 Dec; 54(3):733-741. PubMed ID: 27696251
[TBL] [Abstract] [Full Text] [Related]
20. An integrated approach of network-based systems biology, molecular docking, and molecular dynamics approach to unravel the role of existing antiviral molecules against AIDS-associated cancer.
Omer A; Singh P
J Biomol Struct Dyn; 2017 May; 35(7):1547-1558. PubMed ID: 27484103
[TBL] [Abstract] [Full Text] [Related]
[Next]
